Zhengming Chen

9PUBLICATIONS
122CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.

|Apr 21, 2026
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.

|Mar 20, 2026
A Metal-Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer.

Tiantian Zhang, Xiang Chen, Xiaoxiao Yang

|Feb 18, 2026
Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Jia Ruan, Zhengming Chen, Melissa C Larson

|Nov 25, 2025
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Jia Ruan, David A Bond, Bijal Shah

|Aug 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.

Seda S Tolu, Caitlin Gribbin, Zhengming Chen

Pageof 2

Frequent Collaborators

4 joint publications

Giorgio Inghirami

3 joint publications

David A Bond

3 joint publications

John N Allan

2 joint publications

Bhavneet Bhinder